The Apex Times
Above the Noise
Business Wire
BusinessLarry Fink Says the U.S. May Need More Than 70 Gigawatts of Power to Run AIThe Apex TimesBusinessUber and Zipline set ambition for 1 million daily drone deliveries by 2029The Apex TimesBusinessTarget’s shares hover near a 52-week high as investors look to the next earnings reportThe Apex TimesBusinessServe Robotics links deliveries to Grubhub in Los Angeles after Uber exitThe Apex TimesBusinessGoldman Sachs set to buy ETF provider Neos in deal valued up to $2.3 billionThe Apex TimesBusinessOpenAI to lease new U.S. AI data center for 20 years, with Nvidia-backed financing commitmentThe Apex TimesBusinessAmazon VP says Alexa+ is built for shoppers who want guided assistance, not just voice commandsThe Apex TimesBusinessAT&T’s dividend remains a fixture for income-focused investors, but “how much” depends on yield assumptionsThe Apex TimesBusinessTesla readies Cybercab rollout in August, starting with rides for employees in Austin, report saysThe Apex TimesBusinessUS Commerce Secretary Howard Lutnick urges Apple to avoid Chinese memory chips, raising sourcing questionsThe Apex TimesBusinessBroadcom’s AI “financing” math goes big, but the signed work is smaller for nowThe Apex TimesBusinessVisa shares dip after Ackman discloses a new payment betThe Apex TimesBusinessLarry Fink Says the U.S. May Need More Than 70 Gigawatts of Power to Run AIThe Apex TimesBusinessUber and Zipline set ambition for 1 million daily drone deliveries by 2029The Apex TimesBusinessTarget’s shares hover near a 52-week high as investors look to the next earnings reportThe Apex TimesBusinessServe Robotics links deliveries to Grubhub in Los Angeles after Uber exitThe Apex TimesBusinessGoldman Sachs set to buy ETF provider Neos in deal valued up to $2.3 billionThe Apex TimesBusinessOpenAI to lease new U.S. AI data center for 20 years, with Nvidia-backed financing commitmentThe Apex TimesBusinessAmazon VP says Alexa+ is built for shoppers who want guided assistance, not just voice commandsThe Apex TimesBusinessAT&T’s dividend remains a fixture for income-focused investors, but “how much” depends on yield assumptionsThe Apex TimesBusinessTesla readies Cybercab rollout in August, starting with rides for employees in Austin, report saysThe Apex TimesBusinessUS Commerce Secretary Howard Lutnick urges Apple to avoid Chinese memory chips, raising sourcing questionsThe Apex TimesBusinessBroadcom’s AI “financing” math goes big, but the signed work is smaller for nowThe Apex TimesBusinessVisa shares dip after Ackman discloses a new payment betThe Apex TimesBusinessLarry Fink Says the U.S. May Need More Than 70 Gigawatts of Power to Run AIThe Apex TimesBusinessUber and Zipline set ambition for 1 million daily drone deliveries by 2029The Apex TimesBusinessTarget’s shares hover near a 52-week high as investors look to the next earnings reportThe Apex TimesBusinessServe Robotics links deliveries to Grubhub in Los Angeles after Uber exitThe Apex TimesBusinessGoldman Sachs set to buy ETF provider Neos in deal valued up to $2.3 billionThe Apex TimesBusinessOpenAI to lease new U.S. AI data center for 20 years, with Nvidia-backed financing commitmentThe Apex TimesBusinessAmazon VP says Alexa+ is built for shoppers who want guided assistance, not just voice commandsThe Apex TimesBusinessAT&T’s dividend remains a fixture for income-focused investors, but “how much” depends on yield assumptionsThe Apex TimesBusinessTesla readies Cybercab rollout in August, starting with rides for employees in Austin, report saysThe Apex TimesBusinessUS Commerce Secretary Howard Lutnick urges Apple to avoid Chinese memory chips, raising sourcing questionsThe Apex TimesBusinessBroadcom’s AI “financing” math goes big, but the signed work is smaller for nowThe Apex TimesBusinessVisa shares dip after Ackman discloses a new payment betThe Apex TimesBusinessLarry Fink Says the U.S. May Need More Than 70 Gigawatts of Power to Run AIThe Apex TimesBusinessUber and Zipline set ambition for 1 million daily drone deliveries by 2029The Apex TimesBusinessTarget’s shares hover near a 52-week high as investors look to the next earnings reportThe Apex TimesBusinessServe Robotics links deliveries to Grubhub in Los Angeles after Uber exitThe Apex TimesBusinessGoldman Sachs set to buy ETF provider Neos in deal valued up to $2.3 billionThe Apex TimesBusinessOpenAI to lease new U.S. AI data center for 20 years, with Nvidia-backed financing commitmentThe Apex TimesBusinessAmazon VP says Alexa+ is built for shoppers who want guided assistance, not just voice commandsThe Apex TimesBusinessAT&T’s dividend remains a fixture for income-focused investors, but “how much” depends on yield assumptionsThe Apex TimesBusinessTesla readies Cybercab rollout in August, starting with rides for employees in Austin, report saysThe Apex TimesBusinessUS Commerce Secretary Howard Lutnick urges Apple to avoid Chinese memory chips, raising sourcing questionsThe Apex TimesBusinessBroadcom’s AI “financing” math goes big, but the signed work is smaller for nowThe Apex TimesBusinessVisa shares dip after Ackman discloses a new payment betThe Apex Times
Back to front
CVS Health names Teresa Heitsenrether to board, says Larry Robbins is leaving
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 17, 4:40 PM EDT

CVS Health names Teresa Heitsenrether to board, says Larry Robbins is leaving

The appointment and departure expand and refresh the leadership of CVS Health’s Board of Directors, the company said in a brief announcement.

2 min readEditor-approved Apex article

CVS Health said it is making changes to its Board of Directors, appointing Teresa Heitsenrether and indicating that Larry Robbins will no longer serve on the board. The company’s announcement, reported by Yahoo Finance on Aug. 17, was framed as routine board refreshment rather than as a response to a specific event.

According to the report, Heitsenrether will join the Board of Directors as Robbins exits the board. The company did not provide in the reported item any details on committee assignments, effective dates, or whether the moves are tied to strategic planning, executive succession, or governance matters.

Board changes at large health insurers and pharmacy benefit managers can announcement how leadership is thinking about risk oversight, regulatory scrutiny, and operating priorities across insurance, health services, and pharmacy offerings. However, in this case, the brief disclosure left investors and stakeholders with limited information on what gaps are being filled and how board responsibilities may shift.

Heitsenrether’s appointment is the key addition disclosed in the report. The announcement did not describe her background, the industry expertise she brings, or whether her election affects specific board committees such as audit, compensation, or governance, which are central to how public companies oversee financial reporting and executive pay.

Robbins’ departure is the other major element in the reported update. The company did not say whether Robbins resigned, retired, or completed a term, and it did not specify whether his departure leaves a vacancy on a particular committee. Such details matter because committee composition can influence how quickly new oversight takes effect and how existing work is transferred.

CVS Health, which trades on the NYSE under the ticker CVS, operates across a broad footprint that includes pharmacy benefit services and retail pharmacy, along with health services offered through its network. In that kind of diversified model, board membership often reflects a blend of experience in healthcare delivery, managed care, payer-provider contracting, compliance, and capital allocation.

Still, the disclosure reported by Yahoo Finance did not add color on near-term governance priorities, including whether the board is pursuing any specific initiatives. Without more detail, it remains unclear whether CVS plans to nominate additional directors in the near term or whether the board changes are intended mainly for continuity and renewal.

Why It Matters

  • Board appointments can affect governance oversight, including how the company manages financial reporting, executive compensation, and corporate risk.
  • The departure of a director can shift committee work and may influence how quickly oversight responsibilities are reassigned.
  • For a healthcare company with complex operations, board refreshment can reflect changing priorities, though those priorities were not detailed in the reported announcement.
  • Investors may look for follow-up disclosures, such as committee assignments or biographies, to assess the strategic intent behind the changes.

Sources

Key Facts

  • CVS Health announced the appointment of Teresa Heitsenrether to its Board of Directors.
  • CVS Health also indicated that Larry Robbins is departing from the Board of Directors.
  • The report was published by Yahoo Finance on Aug. 17, 2026.
  • The reported item did not include committee assignments, effective dates, or reasons for the board changes.

Healthcare Related